Molecular and Morphological Profiling of Lung Cancer: A Foundation for “Next-Generation” Pathologists and OncologistsJumpei Kashima(Tokyo Metropolitan Komagome Hospital), Yusuke Okuma(Unknown)CancersApril 29, 201910.3390/cancers11050599Cited by 65SaveCiteExport RISWatch citationsRelated PapersA randomized phase 3 study of ivonescimab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of metastatic non–small cell lung cancer: HARMONi-3.|Journal of Clinical Oncology|2025|2